R. Scott Bitner,Kaitlin E. Browman,Michael E. Brune,Yixian Long,Jurgen Dinges,Karla Drescher,Peer Jacobson,Hwan-soo Jae,Ravi Kurukulasuriya,James T. Link,David J. Madar,Jyoti R. Patel,Marina A. Pliush
申请号：
US14569203
公开号：
US09464072B2
申请日:
2014.12.12
申请国别(地区):
US
年份:
2016
代理人:
摘要：
A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention deficit disorder in general, attention deficit hyperactivity disorder (ADHD), Alzheimers disease (AD), mild cognitive impairment, senile dementia, AIDS dementia, neurodegeneration, depression, and schizophrenia, comprising administering to a patient in need of such treatment an effective amount of a selective inhibitor of the 11-β-hydroxysteroid dehydrogenase Type 1 enzyme activity.
